EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Vitamin D in Infectious Diseases: A Narrative Review Focusing on COVID-19, Long COVID, and Influenza

Olga Adriana Caliman-Sturdza iD, Roxana Elena Gheorghita, Iuliana Soldanescu iD, Mihai Dimian iD, Serghei Mangul

Nutrients · 2026

DOI: 10.3390/nu18040634 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2026. Verfasst von Olga Adriana Caliman-Sturdza und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Biological Sciences, Stefan cel Mare University of Suceava, 720229 Suceava, Romania. Hauptthemen laut MEDLINE: Vitamin D, Influenza, Human, COVID-19, Vitamin D Deficiency. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Research, Innovation and Digitization, project “Artificial intelligence-powered personalized health and genomics libraries for the analysis of long-term effects in COVID-19 patients (AI-PHGL-COVID)”.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vitamin D is a secosteroid hormone traditionally recognized for its role in bone and mineral metabolism, but it is increasingly understood to also function as an important immunomodulator influencing susceptibility to and outcomes of infectious diseases. This narrative review summarizes current evidence on the immunological, clinical, and preventive effects of vitamin D in the context of novel coronavirus disease (COVID-19), post-acute sequelae of SARS-CoV-2 infection (long COVID), and influenza. Mechanistically, vitamin D enhances innate immune defenses through the induction of antimicrobial peptides, including cathelicidin and defensins, and modulates adaptive immunity by suppressing maladaptive Th1/Th17 responses while promoting regulatory T-cell activity. Observational studies have frequently associated vitamin D deficiency with more severe COVID-19 outcomes; however, these associations may be influenced by confounding factors and reverse causality. Some meta-analyses suggest that vitamin D supplementation reduced rates of intensive care unit admission and ventilatory support, particularly among older adults and individuals with low baseline serum 25-hydroxyvitamin D concentrations. Emerging evidence also indicates that inadequate vitamin D status may be associated with an increased risk and symptom burden of long COVID, although causality has not been established. In the case of influenza, a limited number of randomized controlled trials (RCTs) and meta-analyses report a modest but statistically significant reduction in infection risk, especially with daily or weekly vitamin D supplementation in populations with low baseline vitamin D levels. Clinical guidelines consistently recommend maintaining adequate vitamin D status for general health but do not endorse high-dose vitamin D as a treatment for COVID-19 due to inconsistent trial findings. Overall, vitamin D should not be considered a standalone therapeutic agent; rather, maintaining sufficient vitamin D levels represents a low-risk, potentially beneficial strategy to support immune resilience against respiratory viral infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitamin DInfluenza, HumanCOVID-19Vitamin D DeficiencyHumansPost-Acute COVID-19 SyndromeSARS-CoV-2Immunity, InnateDietary SupplementsPandemics

Stichwörter der Autor:innen

SARS-CoV-2immunological mechanismsinfluenzapost-acute sequelae of COVID-19vitamin D

Substanzen

Vitamin D

Autor:innen und Institutionen

  • Faculty of Medicine and Biological Sciences, Stefan cel Mare University of Suceava, 720229 Suceava, Romania.
  • Suceava Emergency Clinical County Hospital, 720224 Suceava, Romania.
  • Integrated Center for Research, Development, and Innovation for Advanced Materials, Nanotechnologies, Manufacturing and Control Distributed Systems (MANSiD), Stefan cel Mare University of Suceava, 720229 Suceava, Romani…
  • Department of Computers, Electronics and Automation, Stefan cel Mare University of Suceava, 720229 Suceava, Romania.
  • Department of Clinical Pharmacy, USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California (USC), Los Angeles, CA 90033, USA.
  • Department of Quantitative and Computational Biology, USC Dornsife College of Letters, Arts and Sciences, University of Southern California (USC), Los Angeles, CA 90089, USA.

ORCID-Profile: Olga Adriana Caliman-Sturdza, Iuliana Soldanescu, Mihai Dimian

Förderung

  • Ministry of Research, Innovation and Digitization
  • project “Artificial intelligence-powered personalized health and genomics libraries for the analysis of long-term effects in COVID-19 patients (AI-PHGL-COVID)”

Zitieren

APA

Caliman-Sturdza, O. A., Gheorghita, R. E., Soldanescu, I., Dimian, M., & Mangul, S. (2026). Vitamin D in Infectious Diseases: A Narrative Review Focusing on COVID-19, Long COVID, and Influenza. Nutrients. https://doi.org/10.3390/nu18040634

Vancouver

Caliman-Sturdza OA, Gheorghita RE, Soldanescu I, Dimian M, Mangul S. Vitamin D in Infectious Diseases: A Narrative Review Focusing on COVID-19, Long COVID, and Influenza. Nutrients. 2026. doi:10.3390/nu18040634

BibTeX
@article{CalimanSturdza2026,
  author = {Caliman-Sturdza, Olga Adriana and Gheorghita, Roxana Elena and Soldanescu, Iuliana and Dimian, Mihai and Mangul, Serghei},
  title = {Vitamin D in Infectious Diseases: A Narrative Review Focusing on COVID-19, Long COVID, and Influenza},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18040634}
}
Kostenlos starten →